Biotin-PEG-maleimide (MW 2000)

Biotin-PEG-maleimide (MW 2000) is a PEG derivative consisting of a linear PEG chain with biotin attached to one end and maleimide modified to the other end. Biotin-PEG-maleimide (MW 2000) anchors drugs or targeting ligands to liposomes or polymer nanocarriers through the maleimide end, and the biotin end is used for in vitro purification or in vivo targeted release[1].

Product Specifications

UNSPSC

12352200

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Others

Smiles

[H][C@]12CS[C@H]([C@]1(NC(N2)=O)[H])CCCCC(NCCOCCN3C(C=CC3=O)=O)=O.[n]

Molecular Weight

2000 (Average)

References & Citations

[1]Chen HA, et al. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly (Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy. Int J Mol Sci. 2020 Apr 13;21 (8) :2690.